Pembrolizumab improves EFS in TNBC
Author:
- 25 February 2022
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Clinical Oncology
- Vol. 19 (4) , 220
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Event-free Survival with Pembrolizumab in Early Triple-Negative Breast CancerNew England Journal of Medicine, 2022